AMPH Amphastar Pharmaceuticals, Inc.
$23.78▲ +1.02%
Healthcare
Other
After hours
$23.78▲ +0.00%
Sep 11, 7:30 PM ET
Volume 400.8K
Avg Volume (10D) 421.2K
Key Metrics & Fundamentals
Market Cap
$1.01B
P/E Ratio
14.1
Div Yield
–%
52W Range
16.65 - 29.52
% vs 50 MA
13.76%
% vs 200 MA
4.70%
RSI-14
67.6
MACD Histogram
+0.0700
Beta (1Y vs SPY)
0.60
Free Cash Flow
$42.73M
Gross Rev
$183.90M
Gross Profit
$93.47M
EBITDA
$61.66M
COGS
$90.43M
Operating Exp
$53.74M
Operating Income
$39.73M
EBIT
$39.73M
Pretax Income
$38.54M
Net Income
$30.35M
EPS (Diluted)
0.67
Price & Volume History
Loading chart…
Recent News
Amphastar Pharmaceuticals (AMPH) Rebounds In Focus, Is It Slightly Overvalued?
Simply Wall St. · Sep 6, 2026 10:13 PM
Amphastar Pharmaceuticals (AMPH) Stock Looks Cheap With Earnings Doing The Heavy Lifting
Simply Wall St. · Sep 5, 2026 10:11 AM
3 Healthcare Stocks We Keep Off Our Radar
StockStory · Sep 1, 2026 1:22 PM
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
PR Newswire · Sep 1, 2026 10:00 AM
Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris
Zacks · Aug 31, 2026 3:10 PM
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
Zacks · Aug 27, 2026 5:06 PM
1 Cash-Producing Stock on Our Buy List and 2 We Question
StockStory · Aug 27, 2026 2:17 PM
Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating
MT Newswires · Aug 18, 2026 3:31 PM
The Top 5 Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings Call
StockStory · Aug 15, 2026 4:13 AM
New Strong Sell Stocks for August 14th
Zacks · Aug 14, 2026 8:06 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See AMPH's money flow as a full page
Social Sentiment
No Reddit posts found for AMPH.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.